Latest Issue

Volume 33 Issue 1

Paper of the Month

Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label Phase II study.

Mariette X, Seror R, Quartuccio L et al.
Université Paris-Sud, Paris, France.
Ann Rheum Dis 2013 Dec 17; Epub ahead of print.
Gerard Espinosa’s review: Belimumab, an inhibitor of B lymphocyte stimulator (BLyS), has been shown to be effective in patients with systemic lupus erythematosus (SLE) and has been approved in the US and Europe for the treatment of this disease.
» Read an expert review of this paper

Webcast

Our most popular articles

Latest news

  • Home
  • Home
  • Home
  • Home
  • Home
  • Home

READER POLL

Rheum poll 1
Which of the following tests for latent TB infection do you initially perform prior to starting anti-TNF or other immunosuppressive therapies in your patients?






Powered by NetPolls

READER SURVEY

SUBMIT AN ARTICLE

OTHER REMEDICA JOURNALS

COMPASS PUBMED SEARCH

Enter your search terms below to search pubmed for articles